Comparison of 2 effect-site concentrations of remifentanil with midazolam during transrectal ultrasound-guided prostate biopsy under procedural analgesia and sedation: A randomized controlled study.
Hou-Chuan LaiChin-Li ChenYi-Hsuan HuangKe-Li WuRen-Chih HuangBo-Feng LinShun-Ming ChanWei-Hung ChanPublished in: Medicine (2022)
In transrectal ultrasound-guided prostate biopsy, target-controlled infusion with remifentanil Minto model target 2.0 ng/mL with 3 to 4 mg midazolam use provided sufficient analgesia and sedation, and appropriate hemodynamic and respiratory conditions.